Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 703
Embargo will expire:
20-Nov-2019 4:00 PM EST
Released to reporters:
19-Nov-2019 2:50 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Nov-2019 4:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

ato-logo.gif

Congressional leaders support radiation oncology community concerns about proposed Medicare alternative payment model

American Society for Radiation Oncology (ASTRO)

Members of Congress from both sides of the aisle issued a series of oversight letters to the Centers for Medicare and Medicaid Services (CMS) in recent months to urge the Agency to adjust its proposed radiation oncology advanced alternative payment model (RO Model). CMS is expected to issue its final determination before the end of 2019.

Channels: All Journal News, Cancer, Government/Law, Healthcare,

Released:
13-Nov-2019 9:30 AM EST
Open in New Tab
Comment
Research Results
ato-logo.gif

ASTRO supports nomination of Dr. Stephen Hahn to lead U.S. Food and Drug Administration

American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) today expressed strong support for the nomination of radiation oncologist Stephen Hahn, MD, FASTRO, as Commissioner of the Food and Drug Administration (FDA). Dr. Hahn served on the ASTRO Board of Directors from 2014 to 2018.

Channels: All Journal News, Cancer, Public Health, Government/Law,

Released:
1-Nov-2019 2:50 PM EDT
Open in New Tab
Comment
Policy
ato-logo.gif

New research suggests proton radiation therapy can benefit patients with challenging liver tumors

American Society for Radiation Oncology (ASTRO)

Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. The studies were published in the International Journal of Radiation Oncology • Biology • Physics, the flagship scientific journal of the American Society for Radiation Oncology (ASTRO).

Channels: All Journal News, Cancer, Cell Biology, Liver Disease,

Released:
30-Oct-2019 8:35 AM EDT
Open in New Tab
Comment
Policy
ato-logo.gif

ASTRO and ACR update practice parameters for radiation therapy treatments

American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) recently released seven updated practice parameters for medical providers who use radiation therapy to treat patients with cancer. The updated practice parameters synthesize the clinical best practices that describe recommended procedures and considerations for the safe delivery of radiation in specific areas of clinical practice.

Channels: All Journal News, Cancer, Healthcare, In the Workplace,

Released:
22-Oct-2019 1:55 PM EDT
Open in New Tab
Comment
Research Results
Newswise: ASTRO honors 2019 Gold Medalists, Honorary Member and other award recipients

ASTRO honors 2019 Gold Medalists, Honorary Member and other award recipients

American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) recognized the recipients of its 2019 Gold Medal awards and other high-profile honors at the 61st ASTRO Annual Meeting in Chicago. View/download photos from the September 17 awards ceremony online.

Channels: Cancer, Immunology, Respiratory Diseases and Disorders,

Released:
2-Oct-2019 12:05 PM EDT
Open in New Tab
Comment
Research Results
ato-logo.gif

Noninvasive radiation treatment offers long-term benefits to patients with high-risk heart arrhythmias

American Society for Radiation Oncology (ASTRO)

Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Channels: Cardiovascular Health, Heart Disease, Medical Meetings,

Released:
26-Sep-2019 11:05 AM EDT
Open in New Tab
Comment
Announcement
ato-logo.gif

PACIFIC survival rates explained: Lung cancer spread reduced, new distant growth most often in the brain

American Society for Radiation Oncology (ASTRO)

A new analysis of survival data for the randomized, phase III PACIFIC trial finds adding the immunotherapy cancer drug durvalumab to radiation and chemotherapy significantly decreased the recurrence of lung cancer both in the chest area and in distant sites outside the chest. The update, which provides greater insight into the landmark study that changed the standard of care for patients with stage 3 unresectable non-small-cell lung cancer (NSCLC), were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Channels: Cancer, Immunology, Neuro, Medical Meetings,

Released:
26-Sep-2019 11:05 AM EDT
Open in New Tab
Comment
Research Results
ato-logo.gif

Trial reports randomized evidence high-dose radiation is effective for men whose prostate cancer has spread

American Society for Radiation Oncology (ASTRO)

A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy. The phase II trial found that radiation therapy can generate an immune system response not previously believed possible in this type of cancer. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Channels: Cancer, Men's Health, Medical Meetings,

Released:
26-Sep-2019 11:05 AM EDT
Open in New Tab
Comment
Research Results
ato-logo.gif

Women equally satisfied with cosmetic results of both partial and whole breast radiation therapy after lumpectomy

American Society for Radiation Oncology (ASTRO)

Whole breast radiation and partial breast radiation following a lumpectomy yield similar cosmetic outcomes for women diagnosed with early stages of cancer who wish to preserve their breasts. Findings of the new analysis from a phase III clinical trial were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Channels: Cancer, Women's Health, Medical Meetings,

Released:
26-Sep-2019 11:05 AM EDT
Open in New Tab
Comment
Research Results

Showing results

110 of 703

Chat now!
0.85227